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http://www.biomedcentral.com/1471-2474/13/254RESEARCH ARTICLE Open AccessObesity and increased burden of hip and knee
joint disease in Australia: Results from a national
survey
Ilana N Ackerman1* and Richard H Osborne2Abstract
Background: Research involving more representative samples is needed to extend our understanding of the
broader impact of obesity in hip or knee joint disease (arthritis and OA) beyond clinical settings. Although
population-based research has been conducted in the United States, how these findings translate to other
countries is unclear. Using a national approach, this study explored associations between obesity and the burden of
hip and knee joint disease in Australia (in terms of prevalence, pain, stiffness, function, Health-Related Quality of Life
(HRQoL) and disease severity).
Methods: A random sample of 5000 Australians (≥39 years) from the federal electoral roll was invited to complete
a mailed questionnaire to identify doctor-diagnosed hip arthritis, hip OA, knee arthritis and knee OA and evaluate
the burden of these conditions. Validated questionnaires included the WOMAC Index, Assessment of Quality of Life
instrument and Multi-Attribute Prioritisation Tool. Body Mass Index (BMI) was classified into underweight/normal
weight (≤24.99 kg/m2), overweight (25–29.99) or obese (≥30). Multiple logistic regression was used to estimate
odds of arthritis and OA, with demographic and socioeconomic variables included in the models. Associations
between BMI and other variables were investigated using analysis of covariance, with adjustment for age and sex.
Results: Data were available from 1,157 participants (23%). Overweight participants had increased odds of knee
arthritis (adjusted OR (AOR) 1.87, 95%CI 1.14-3.07) and knee OA (AOR 2.11, 95%CI 1.07-4.15). Obesity was associated
with higher prevalence of hip arthritis (AOR 2.18, 95%CI 1.17-4.06), knee arthritis (AOR 5.47, 95%CI 3.35-8.95)
and knee OA (AOR 7.35, 95%CI 3.85-14.02). Of those with arthritis or OA, obese individuals reported more pain
(for hip arthritis, hip OA and knee OA), greater stiffness (for hip arthritis, knee arthritis and knee OA), worse function
(all diagnoses), lower HRQoL (for hip arthritis and hip OA) and greater disease severity (all diagnoses).
Conclusions: This national study has demonstrated that the odds of arthritis and OA was up to 7 times higher for
obese individuals, compared with those classified as underweight/normal weight. Concurrent obesity and joint
disease had a marked impact on several key aspects of wellbeing, highlighting the need for public health
interventions.
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Hip and knee joint disease (arthritis and osteoarthritis
(OA)) are ongoing public health challenges internation-
ally, which are set to worsen with ageing populations.
The number of hip and knee replacements in Australia
has almost doubled in the past decade and over 80,000
procedures are now undertaken annually, predominantly
for OA [1]. In recent years, the prevalence of obesity has
also risen substantially in many countries including Australia,
Canada and the United States (US) [2], with 61% of
Australian adults considered to be overweight or obese
[3]. Overweight and obesity represent the third highest
risk factors for the burden of illness in Australia, after
smoking and hypertension [3].
Obesity is thought to contribute to the development
and progression of OA through increased mechanical
load and more recently, via hormonal and metabolic
mechanisms [4,5]. There is some evidence to support a
relationship between obesity and risk of hip OA [6], and
several large studies have shown a clear link between
obesity and risk of knee OA [7-12]. To date, the associ-
ation between obesity and burden of hip and knee joint
disease (in terms of prevalence and impact) has not been
explored in Australia. Specific data pertaining to the hip
and knee joints are not available from Australian
population-based studies, including the triennial National
Health Survey and state-based health surveys, which have
collected data on self-reported arthritis and OA affecting
any joint/s [13-16]. Nonetheless, two studies from single
Australian states have identified a relationship between in-
creasing Body Mass Index (BMI) and risk of non-specific
arthritis. Analysis of data from the Victorian Population
Health Survey showed that overweight individuals were
60% more likely to have arthritis and those who were
obese had twice the risk [13]. A similar relationship be-
tween obesity and risk of general arthritis was also evident
from the South Australian Health Omnibus Survey [14].
Information on obesity as both a risk factor and a
determinant of quality of life is important for under-
standing how to deal with hip and knee joint disease at a
population level. However, many studies investigating the
relationship between obesity and the impact of hip and
knee OA have been conducted in clinical settings, with
limited generalisability. Overweight and obesity have
been associated with impaired quality of life in a primary
care study of patients with hip or knee OA [17] and most
recently, computer simulation models demonstrated a
substantial expected loss of quality-adjusted life years for
obese individuals with knee OA [18]. Australian research
involving obese adults recruited from gastric banding
and weight loss programs found that a knee OA sub-
group had poorer physical functioning, increased bodily
pain and lower Health-Related Quality of Life (HRQoL),
compared to those without OA [19]. Clinical studies andthose involving convenience samples have also found
obesity to be associated with increased pain [20-22],
worse health status [22] and greater disability in hip or
knee OA [22-24], although the applicability of these find-
ings to other settings is not clear.
Research using more representative samples is
needed to extend our understanding of the personal
impact of concurrent obesity and hip or knee joint dis-
ease beyond primary care and outpatient settings. The
use of population-based sampling enables recruitment
of people with a range of disease severity, including
those with less severe joint disease who may not be re-
ceiving treatment and are therefore unlikely to be
included in clinical studies. This is important for ensur-
ing that research findings are relevant across the disease
severity spectrum, and not limited to only those with more
severe joint disease. Additionally, population-based sam-
pling facilitates the recruitment of people from varied
socioeconomic backgrounds, representing an advance over
clinical studies which commonly comprise patients from a
limited catchment area. To date, our understanding of the
relationship between obesity and personal impact of arth-
ritis or OA comes predominantly from population-based
research conducted in the US [25-29]. Most studies in this
area have focused on functional status, disability and activ-
ity limitations, although other population-based studies
(for example, those investigating racial differences in pain
among people with knee OA [30,31]) have included Body
Mass Index (BMI) as part of a range of covariates.
Whether the impact of obesity is similar in other countries
is not known and further investigation of the relationships
between obesity and pain, function and HRQoL in hip and
knee joint disease in other populations is warranted.
Using a national approach, this study aimed to:
1. investigate associations between obesity and the
prevalence of hip and knee joint disease (arthritis and
OA) in Australia; and
2. explore associations between obesity and pain,
stiffness, physical function, HRQoL and disease
severity among people with hip or knee joint disease.
Methods
Study design
This paper reports the results of a national cross-
sectional survey.
Participants
As electoral enrolment and voting is compulsory for
Australians aged 18 years and over, the federal electoral
roll provides comprehensive coverage of the Australian
adult population. Medical researchers can apply for an
electoral roll extract for use in research or public health
screening programs. In May 2009, following approval by
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Committee and the Australian Electoral Commission,
we obtained an extract which included the names, age
group, sex and postal address details for a random sam-
ple of 10,000 individuals drawn from all federal electoral
divisions. This extract was used to randomly select a
sample of the Australian population aged 39 years and
over from all states and territories (N=5,000), stratified
by age range category. The lowest two age categories
(39–43 years and 44–48 years) were over-sampled to in-
crease precision, as the prevalence of arthritis is lower
among younger people [13,32].Procedure
In June 2009, an introductory letter, plain language state-
ment and questionnaire were mailed to the selected sam-
ple (Figure 1). Reply-paid envelopes were provided to
maximize response rates. To minimise participant bur-
den and maximise response rates, return of a completed
questionnaire was deemed to constitute consent. This
procedure was approved by The University of Melbourne
Human Research Ethics Committee. Limited follow-up
with repeat administration of the study questionnaire was
undertaken for a random sample of non-participants ap-
proximately 6 weeks after the initial mailing (stratified by
state/territory, n=300). All questionnaires marked ‘return
to sender’ were re-sent where an alternative postal address
could be located.
Although hip OA and knee OA were the primary condi-
tions of interest, previous studies have indicated that indi-
vidual knowledge of arthritis type can be limited [16,33].
The questionnaire was therefore designed to screen for
the presence of doctor-diagnosed hip OA and knee OA
and doctor-diagnosed hip arthritis and knee arthritis to
capture the majority of possible OA cases. Screening was
performed using self-reported measures, similar to the
methodology used by the US Centers for Disease Control
[33]. Participants were asked:
 “have you ever been told by a doctor or other health
professional that you have hip arthritis?”;
 “have you ever been told by a doctor or other health
professional that you have hip osteoarthritis?”;
 “have you ever been told by a doctor or other health
professional that you have knee arthritis?”; and
 “have you ever been told by a doctor or other health
professional that you have knee osteoarthritis?”
Individuals who reported having x-rays that showed
hip or knee arthritis or OA but did not report a doctor’s
diagnosis for these conditions were excluded from the
analyses (n=7, <1% for hip arthritis or hip OA; n=5, <1%
for knee arthritis or knee OA).Instruments
Three validated instruments were included in the study
questionnaire. The Western Ontario and McMaster
Universities Osteoarthritis (WOMAC) Index is a disease-
specific measure of health status widely used in OA
research [34], with demonstrated validity, reliability and
responsiveness [35,36]. It produces pain, stiffness and
physical function subscale scores commonly transformed
to 0 (best health) to 100 (worst health) scales. Among par-
ticipants with hip or knee arthritis or OA, the total
WOMAC score was used to classify joint disease severity,
as reported previously [37]. A WOMAC score <7 was
considered to be asymptomatic joint disease, 7–38 was
considered to be mild-moderate disease and ≥39 was con-
sidered to be severe joint disease. The Assessment of
Quality of Life (AQoL) instrument is an Australian generic
measure of HRQoL which was developed using the World
Health Organization’s (WHO) definition of health and
classification of impairments, disabilities and handicaps
[38,39]. The four dimensions covered by this instrument
include Independent Living, Social Relationships, Physical
Senses and Psychological Wellbeing. The AQoL instru-
ment has demonstrated good internal consistency, and
face, content and construct validity [40]. It has been used
in arthritis research [40,41] and Australian normative
data are available [39]. The AQoL instrument produces
a utility score ranging from −0.04 (worst HRQoL) to
1.00 (full HRQoL). The Hip and Knee Multi-Attribute
Prioritisation Tool (MAPT) is a measure of OA disease se-
verity and need for joint replacement surgery. The MAPT
is used in all public hospitals in the state of Victoria to
specifically facilitate prioritisation and care pathway triage
for people with OA who may need hip or knee joint re-
placement. Although it has been shown to correlate with
the WOMAC Index [42], the MAPT captures additional
information relevant to hip and knee OA. Developed
through intensive stakeholder consultation, it covers a
range of constructs important to both patients and ortho-
paedic surgeons including pain, self-care activities, mental
health, overall worsening and the ability to manage finan-
cially, care for others and maintain relationships. The
MAPT has demonstrated construct validity and test-retest
reliability in a large validation study [42] and produces a
score ranging from 0 (least disease severity) to 100 (great-
est severity).
Other self-reported data included country of birth, mari-
tal status, highest level of education, height, weight, paid
and unpaid employment and premature exit from the
workforce. BMI was calculated using self-reported height
and weight and classified into underweight/normal weight
(BMI ≤24.99 kg/m2), overweight (BMI 25–29.99) and
obese categories (BMI ≥30), according to World Health
Organization definitions [43]. Residential location was
classified as metropolitan or provincial/rural based on
Approval received from the Australian 
Electoral Commission 
Obtained extract from federal electoral roll, 
containing random sample from all states and 
territories (N=10,000)
Random sample ≥39 years selected, stratified 
by age category (N=5,000):
Australian Capital Territory (N=375)
New South Wales (N=750)
Northern Territory (N=250)
Queensland (N=750)
South Australia (N=750)
Tasmania (N=375)
Victoria (N=1000)
Western Australia (N=750)
Introductory letter, plain language statement 
and study questionnaire sent
Limited follow-up of random sample of non-
respondents, stratified by state/territory 
(N=300)
Questionnaires returned (N=1158)
All ‘return to sender’ mail re-sent, where an 
alternative address could be located
1 respondent found to be aged <39 years was
excluded from the analyses 
Data available for analysis from 1157 
respondents
Figure 1 Sample selection and recruitment.
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economic status was approximated using postcodes to link
to the Australian Socio-Economic Indexes for Areas
(SEIFA) 2006 Index of Relative Socio-Economic Advantage
and Disadvantage [45]. The first SEIFA decile represents
geographical areas with the greatest socioeconomic disad-
vantage while the tenth decile represents areas with the
greatest advantage.
Statistical analysis
Analyses were undertaken using SPSS 18.0 and Stata 10.1.
Only limited demographic information (sex, age group,
socioeconomic status and location) was available for non-
participants; chi-square tests were used to evaluate differ-
ences between participants and non-participants.
Based on affirmative responses to the screening ques-
tions, the overall prevalence of hip or knee arthritis or OA
and Clopper-Pearson confidence interval estimates were
calculated. Prevalence was also calculated according to sex,
age, BMI, education, marital status, country of birth, loca-
tion and socioeconomic status (Additional file 1). Multiple
binary logistic regression was used to generate adjusted
odds ratios for the odds of hip and knee arthritis and OA,
with demographic and socioeconomic variables entered
simultaneously as predictors. Reference categories included
male sex, age <50 years, BMI ≤24.99 kg/m2 (underweight/
normal weight), primary school or less level of education,
married/living with partner, born in Australia, residing in a
metropolitan location and first SEIFA decile (greatest
socioeconomic disadvantage) (Additional file 1).
For participants who reported hip or knee arthritis or
OA, analysis of covariance (ANCOVA) was used to
evaluate associations between BMI category and pain,
stiffness, physical function and HRQoL (with adjustment
for age and sex). Post-hoc tests used a Bonferroni adjust-
ment for multiple comparisons. Kruskal-Wallis tests
were used to evaluate the relationship between BMI cat-
egory and disease severity as the distribution of MAPT
scores was severely skewed and this was not improved
by log transformation.
Results
Participants
Questionnaires were returned by 1,158 individuals (23%
response rate). Limited information was available for
non-participants: questionnaires were returned for 91
individuals (2%) due to incorrect address details, 45 indi-
viduals (1%) declined to participate and 1 had died. One
respondent was found to be aged less than 39 years
(having been incorrectly listed in the 69–73 year age cat-
egory in the federal electoral roll extract) and was subse-
quently excluded from the analyses. Age data for all
analyses were calculated based on self-reported date of
birth from the study questionnaire.Response rates by state ranged from 15% to 31%. The
Northern Territory had the lowest response rate, as well
as the highest proportion of return to sender mail; this
may relate to the remoteness of many areas in the terri-
tory and the larger indigenous population.
Comparison of participants and non-participants
Although absolute differences between participants and
non-participants were small, a greater proportion of partici-
pants were female (57% vs 52% for non-participants, chi-
square=8.3, p<0.01) and living in areas with the highest
socioeconomic advantage (17% vs 14% for non-participants,
chi-square=22.9, p=0.01). A lower proportion of younger
age groups was also seen among participants (14% aged
39–43 years and 15% aged 44–48 years vs 21% each for
non-participants, chi-square=90.5, p<0.01). Sixty-seven
per cent in both groups lived in metropolitan areas (chi-
square=0.0, p=0.90).
Demographics
The demographic characteristics of the sample are sum-
marized in Table 1.
Overall prevalence of hip and knee arthritis and
osteoarthritis
Eighty-three participants reported having ever been told
by a doctor or other health professional that they had
hip arthritis (7%, 95%CI 6%-9%), and 57 reported hip
OA (5%, 95%CI 4%-6%). There was some overlap be-
tween the hip arthritis and hip OA groups; of those who
had been told they had hip arthritis, 57% (n=47) also
reported hip OA. Of those with hip arthritis or hip OA
(n=93), 8% were classified as asymptomatic, 45% as mild
to moderate and 40% as severe; WOMAC scores were
missing for the remaining 8%.
One hundred and sixty-nine participants reported hav-
ing been told they had knee arthritis (15%, 95%CI 13%-
17%) and 98 reported knee OA (8%, 95%CI 7%-10%). Of
those who reported knee arthritis, 41% (n=69) also said
they had been diagnosed with knee OA. Of those with
knee arthritis or knee OA (n=198), 15% were classified as
asymptomatic, 52% as mild to moderate and 27% as se-
vere; WOMAC scores were missing for the remaining 7%.
Overweight and obesity and odds of hip arthritis and
osteoarthritis
After adjusting for demographic characteristics, obesity
was associated with a higher prevalence of hip arthritis
(Table 2). Participants who were obese were more than
twice as likely to have hip arthritis (adjusted OR (AOR)
=2.18, 95%CI 1.17-4.06), compared with those classified as
underweight/normal weight. A higher prevalence of hip
arthritis was also associated with increasing age (Table 2).
Compared with the youngest age group, participants aged
Table 1 Demographic characteristics of study participants
Characteristic Overall sample
(n=1157)*
Age (years), median (IQR) 57 (48–69)
Female, n (%) 656 (57)
Body Mass index (BMI) (kg/m2), n (%)
Underweight / normal weight (BMI ≤24.99 kg/m2) 430 (37)
Overweight (BMI 25–29.99 kg/m2) 383 (33)
Obese (BMI ≥30 kg/m2) 248 (21)
Married or living with partner, n (%) 924 (80)
Living in metropolitan area, n (%) 775 (67)
SEIFA† decile, n (%)
First (greatest socioeconomic disadvantage) 56 (5)
Tenth (greatest socioeconomic advantage) 200 (17)
Highest level of education completed, n (%)
Primary school or less 54 (5)
Year 7-10 263 (23)
Year 11-12 213 (18)
Trade / technical education 260 (23)
University 356 (31)
Australian-born, n (%) 894 (77)
English as main language spoken at home, n (%) 1104 (95)
Paid work, n (%)
Paid employment 651 (56)
Retired 426 (37)
Unemployed 58 (5)
Stopped work due to hip or knee arthritis / OA 7 (<1)
Unpaid work, n (%)
Currently does unpaid work 335 (29)
Unable to do unpaid work due to hip or knee
arthritis / OA
33 (3)
Does not do unpaid work for other reasons 713 (62)
*Total numbers for characteristics may not equal 1157 due to missing
responses.
†Australian Socio-Economic Indexes for Areas 2006 Index of Relative
Socio-Economic Advantage and Disadvantage.
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ritis (AOR=6.86, 95%CI 2.54-18.50), followed by those
aged 70–79 years (AOR=5.13, 95%CI 2.29-11.49).
For hip OA, no association between obesity and preva-
lence was observed (Table 2). An increased prevalence
of hip OA was associated with being female (AOR=3.39,
95%CI 1.59-7.22) and aged 70–79 years (AOR=4.35, 95%
CI 1.79-10.56).
Overweight and obesity and odds of knee arthritis and
osteoarthritis
Higher BMI was strongly associated with an increased
prevalence of knee arthritis (Table 3). After adjusting forother demographic characteristics, participants who were
overweight were more likely to report knee arthritis (AOR
1.87, 95%CI 1.14-3.07) while those who were obese had the
highest odds (AOR=5.47, 95%CI 3.35-8.95). The prevalence
of knee arthritis also increased substantially with age; those
aged 70–79 years and 80 years or over had the greatest
odds (AOR=3.16, 95%CI 1.67-5.99 and AOR=5.26, 95%CI
2.44-11.35, respectively). A lower prevalence of knee arth-
ritis was seen among participants who had completed high
school (AOR=0.25, 95%CI 0.11-0.60), trade or technical
qualifications (AOR=0.28, 95%CI 0.13-0.65) or university
(AOR=0.34, 95%CI 0.15-0.78), compared to those who had
completed primary school or less.
Similar to the knee arthritis group, overweight and obes-
ity were clearly associated with an increased prevalence of
knee OA (Table 3). Participants who were overweight had
increased odds of having knee OA (AOR=2.11, 95%CI
1.07-4.15) while the obese group had the highest odds
(AOR=7.35, 95%CI 3.85-14.02). The prevalence of knee
OA was also higher in those aged 60–69 years (AOR=2.76,
95%CI 1.34-5.69) and 70–79 years (AOR=2.78, 95%CI
1.26-6.11). Participants who were single, divorced or
widowed were more likely to have knee OA (AOR=2.11,
95%CI 1.23-3.62) while those who had completed high
school were less likely to have knee OA (AOR 0.34, 95%CI
0.12-0.98).
Impact of overweight and obesity in hip arthritis and
osteoarthritis
Table 4 shows that among participants with hip arthritis,
pain increased significantly with greater BMI (F=5.35,
p=0.01). Post-hoc tests showed that participants who
were obese had the highest pain (adjusted mean 44.3,
95%CI 34.3-54.4), compared to those classified as under-
weight/normal weight (adjusted mean 23.1, 95%CI 13.8-
32.4). A similar pattern was seen for stiffness; those who
were obese reported the greatest stiffness, compared to
individuals in the underweight/normal weight group
(F=3.66, p=0.03). Post-hoc analyses indicated that parti-
cipants in both the overweight and obese groups had
worse physical function (adjusted mean 43.8, 95%CI
32.1-55.5 and 45.5, 95%CI 35.2-55.7, respectively), com-
pared to those in the underweight/normal weight group
(adjusted mean 23.8, 95%CI 14.1-33.4).
Regardless of BMI category, the average HRQoL of
participants with hip arthritis was well below Australian
population norms (mean AQoL 0.83, 95%CI 0.82-0.84,
minimal important difference ~0.06 AQoL units [39]).
Further deterioration in HRQoL was evident with increas-
ing BMI (F=4.44, p=0.02); there was a significant differ-
ence in HRQoL between participants who were obese
(adjusted mean 0.43, 95%CI 0.31-0.55) and those classified
as underweight/normal weight (adjusted mean 0.66, 95%
CI 0.55-0.77). Increasing BMI was also associated with
Table 2 Prevalence and odds of hip arthritis and osteoarthritis according to demographic characteristics
Hip arthritis Hip osteoarthritis
Characteristic Prevalence
n (%)
Unadjusted OR
(95%CI)
Adjusted OR*
(95%CI)
Prevalence
n (%)
Unadjusted OR
(95%CI)
Adjusted OR*
(95%CI)
Sex
Male (n=500) 19 (4) 1.00 1.00 13 (3) 1.00 1.00
Female (n=656) 64 (10) 2.74 (1.62-4.63) 3.70 (1.98-6.91) 44 (7) 2.69 (1.43-5.05) 3.39 (1.59-7.22)
Age group
<50 years (n=363) 14 (4) 1.00 1.00 11 (3) 1.00 1.00
50-59 years (n=290) 10 (3) 0.89 (0.39-2.04) 0.97 (0.39-2.41) 3 (1) 0.33 (0.09-1.21) 0.37 (0.10-1.39)
60-69 years (n=230) 17 (7) 1.99 (0.96-4.12) 2.01 (0.87-4.61) 15 (7) 2.23 (1.01-4.95) 1.95 (0.78-4.88)
70-79 years (n=178) 29 (16) 4.89 (2.51-9.51) 5.13 (2.29-11.49) 23 (13) 4.81 (2.29-10.11) 4.35 (1.79-10.56)
≥80 years (n=82) 13 (16) 4.77 (2.15-10.59) 6.86 (2.54-18.50) 5 (6) 2.13 (0.72-6.32) 1.89 (0.50-7.18)
Body Mass Index (BMI)
Underweight / normal weight (n=430) 28 (7) 1.00 1.00 18 (4) 1.00 1.00
Overweight (n=383) 20 (5) 0.79 (0.44-1.43) 1.00 (0.53-1.89) 16 (4) 1.00 (0.50-1.98) 1.17 (0.56-2.44)
Obese (n=248) 26 (10) 1.68 (0.96-2.93) 2.18 (1.17-4.06) 16 (6) 1.58 (0.79-3.16) 1.62 (0.77-3.45)
Highest level of education
Primary school or less (n=54) 8 (15) 1.00 1.00 6 (11) 1.00 1.00
Year 7–10 (n=263) 31 (12) 0.75 (0.32-1.74) 1.01 (0.37-2.76) 19 (7) 0.62 (0.23-1.62) 0.62 (0.20-1.94)
Year 11–12 (n=213) 12 (6) 0.34 (0.13-0.87) 0.53 (0.17-1.64) 10 (5) 0.39 (0.13-1.12) 0.49 (0.14-1.73)
Trade / technical (n=260) 15 (6) 0.34 (0.14-0.86) 0.74 (0.25-2.18) 10 (4) 0.31 (0.11-0.90) 0.64 (0.19-2.17)
University (n=356) 17 (5) 0.28 (0.12-0.69) 0.67 (0.22-1.99) 12 (3) 0.27 (0.10-0.77) 0.47 (0.14-1.62)
Marital status
Married / living with partner (n=924) 61 (7) 1.00 1.00 41 (4) 1.00 1.00
Single / divorced / widowed (n=222) 22 (10) 1.56 (0.94-2.61) 0.94 (0.50-1.76) 16 (7) 1.70 (0.93-3.08) 1.17 (0.57-2.41)
Country of birth
Australia (n=894) 59 (7) 1.00 1.00 42 (5) 1.00 1.00
Other (n=255) 24 (9) 1.47 (0.89-2.41) 1.73 (0.98-3.07) 15 (6) 1.27 (0.69-2.33) 1.25 (0.62-2.49)
Location
Metropolitan (n=775) 56 (7) 1.00 1.00 40 (5) 1.00 1.00
Provincial or rural (n=381) 27 (7) 0.98 (0.61-1.57) 0.70 (0.36-1.35) 17 (4) 0.86 (0.48-1.53) 0.79 (0.37-1.71)
OR: odds ratio; 95%CI: 95% confidence interval.
*Adjusted values were derived from multiple binary logistic regression models with sex, age group, BMI, highest level of education, marital status, country of birth,
location and SEIFA decile entered simultaneously as predictors.
Socioeconomic status (SEIFA) data for hip arthritis and osteoarthritis are presented in the Additional file 1 (Table A1).
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p=0.01). Participants who were obese had the greatest se-
verity (median 14.1, IQR 2.3-55.7), followed by those who
were overweight (median 8.1, IQR 0.0-38.6). Those classi-
fied as underweight/normal weight had the least severe
disease (median 0.0, IQR 0.0-7.5).
For participants with hip OA, increased pain was also
associated with greater BMI (F=4.04, p=0.03). Those
classified as obese had higher pain (adjusted mean 50.4,
95%CI 36.6-64.2), compared to participants in the under-
weight/normal weight group (adjusted mean 24.2, 95%CI
11.9-36.5). There was a trend towards greater stiffness
with increasing BMI but this was not significant (F=2.55,p=0.09). Obese participants also had worse physical func-
tion (F=3.68, p=0.03), markedly lower HRQoL (F=4.48,
p=0.02) and greater disease severity (Kruskal-Wallis chi
square=9.5, p=0.01), compared to those classified as
underweight/normal weight (Table 4). Those with hip
OA who were obese had extremely low HRQoL, com-
pared to population norms (mean AQoL score 0.32, 95%
CI 0.18-0.47).
Impact of overweight and obesity in knee arthritis and
osteoarthritis
In knee arthritis, greater stiffness was associated with
increased BMI (F=4.76, p=0.01); participants who were
Table 3 Prevalence and odds of knee arthritis and osteoarthritis according to demographic characteristics
Knee arthritis Knee osteoarthritis
Characteristic Prevalence
n (%)
Unadjusted OR
(95%CI)
Adjusted OR*
(95%CI)
Prevalence
n (%)
Unadjusted OR
(95%CI)
Adjusted OR*
(95%CI)
Sex
Male (n=500) 71 (14) 1.00 1.00 36 (7) 1.00 1.00
Female (n=656) 98 (15) 1.07 (0.77-1.49) 1.15 (0.77-1.71) 62 (9) 1.34 (0.87-2.06) 1.51 (0.91-2.52)
Age group
<50 years (n=363) 25 (7) 1.00 1.00 15 (4) 1.00 1.00
50-59 years (n=290) 39 (13) 2.10 (1.24-3.55) 1.95 (1.09-3.48) 18 (6) 1.55 (0.77-3.13) 1.36 (0.64-2.88)
60-69 years (n=230) 37 (16) 2.60 (1.52-4.45) 1.99 (1.08-3.66) 31 (13) 3.65 (1.92-6.93) 2.76 (1.34-5.69)
70-79 years (n=178) 45 (25) 4.67 (2.75-7.92) 3.16 (1.67-5.99) 26 (15) 4.00 (2.06-7.76) 2.78 (1.26-6.11)
≥80 years (n=82) 22 (27) 5.03 (2.66-9.50) 5.26 (2.44-11.35) 7 (9) 2.29 (0.90-5.81) 1.99 (0.65-6.08)
Body Mass Index (BMI)
Underweight / normal weight (n=430) 36 (8) 1.00 1.00 15 (3) 1.00 1.00
Overweight (n=383) 49 (13) 1.61 (1.02-2.54) 1.87 (1.14-3.07) 27 (7) 2.10 (1.10-4.00) 2.11 (1.07-4.15)
Obese (n=248) 68 (27) 4.21 (2.71-6.54) 5.47 (3.35-8.95) 49 (20) 6.83 (3.74-12.48) 7.35 (3.85-14.02)
Highest level of education
Primary school or less (n=54) 19 (35) 1.00 1.00 10 (19) 1.00 1.00
Year 7–10 (n=263) 58 (22) 0.50 (0.27-0.95) 0.56 (0.26-1.21) 30 (11) 0.55 (0.25-1.21) 0.50 (0.19-1.32)
Year 11–12 (n=213) 24 (11) 0.22 (0.11-0.45) 0.25 (0.11-0.60) 13 (6) 0.28 (0.11-0.67) 0.34 (0.12-0.98)
Trade / technical (n=260) 27 (10) 0.20 (0.10-0.40) 0.28 (0.13-0.65) 16 (6) 0.28 (0.12-0.65) 0.36 (0.13-1.01)
University (n=356) 40 (11) 0.22 (0.11-0.42) 0.34 (0.15-0.78) 28 (8) 0.36 (0.16-0.79) 0.40 (0.15-1.11)
Marital status
Married / living with partner (n=924) 119 (13) 1.00 1.00 67 (7) 1.00 1.00
Single / divorced / widowed (n=222) 47 (21) 1.83 (1.26-2.66) 1.50 (0.96-2.36) 29 (13) 1.98 (1.24-3.14) 2.11 (1.23-3.62)
Country of birth
Australia (n=894) 131 (15) 1.00 1.00 70 (8) 1.00 1.00
Other (n=255) 37 (15) 0.98 (0.66-1.46) 1.16 (0.74-1.82) 27 (11) 1.39 (0.87-2.23) 1.62 (0.95-2.78)
Location
Metropolitan (n=775) 113 (15) 1.00 1.00 67 (9) 1.00 1.00
Provincial or rural (n=381) 56 (15) 1.01 (0.72-1.44) 0.88 (0.54-1.44) 31 (8) 0.94 (0.60-1.46) 1.00 (0.54-1.85)
OR: odds ratio; 95%CI: 95% confidence interval.
*Adjusted values were derived from multiple binary logistic regression models with sex, age group, BMI, highest level of education, marital status, country of birth,
location and SEIFA decile entered simultaneously as predictors.
Socioeconomic status (SEIFA) data for knee arthritis and osteoarthritis are presented in the Additional file 1 (Table A2).
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http://www.biomedcentral.com/1471-2474/13/254obese reported more stiffness (adjusted mean 40.6, 95%CI
34.6-46.7) than those in the underweight/normal weight
group (adjusted mean 25.6, 95%CI 17.2-34.0). Participants
who were obese also had worse function (adjusted mean
35.9, 95%CI 30.2-41.6), compared to those classified as
underweight/normal weight (adjusted mean 20.7, 95%CI
12.7-28.7). Participants in the obese group had, on aver-
age, greater disease severity (median 6.1, IQR 0.0-23.7;
Kruskal-Wallis chi-square=8.6, p=0.01).
Among participants with knee OA, those classified as
obese had higher pain (adjusted mean 40.1, 95%CI 33.0-
47.1) than participants who were overweight (adjusted
mean 24.0, 95%CI 14.6-33.4). Participants who wereobese also had greater stiffness (F=5.48, p=0.01) and
worse physical function (F=6.39, p<0.01), compared to
both the overweight and underweight/normal weight
groups. Obesity was also associated with increased dis-
ease severity (Kruskal-Wallis chi-square=10.2, p=0.01).
Discussion
Using a national, population health approach, this re-
search is the first to explore the relationship between
obesity and the burden of hip and knee joint disease in
Australia. This study has shown that overweight was
associated with greater likelihood of having knee arth-
ritis and knee OA, and that obesity was associated with
Table 4 Impact of overweight and obesity
Outcome n Underweight or normal weight n Overweight n Obese p
Hip arthritis
WOMAC pain 28 23.1 (13.8-32.4) 18 40.8 (29.4-52.2) 25 44.3 (34.3-54.4) 0.01
WOMAC stiffness 28 31.7 (22.3-41.1) 18 43.9 (32.3-55.5) 26 50.4 (40.4-60.3) 0.03
WOMAC function 27 23.8 (14.1-33.4) 18 43.8 (32.1-55.5) 25 45.5 (35.2-55.7) 0.01
AQoL 28 0.66 (0.55-0.77) 18 0.48 (0.34-0.62) 25 0.43 (0.31-0.55) 0.02
MAPT 26 0.0 (0.0-7.5) 18 8.1 (0.0-38.6) 25 14.1 (2.3-55.7) 0.01
Hip osteoarthritis
WOMAC pain 18 24.2 (11.9-36.5) 14 34.0 (19.8-48.2) 15 50.4 (36.6-64.2) 0.03
WOMAC stiffness 18 34.7 (23.4-46.1) 14 41.6 (28.5-54.6) 16 53.5 (41.2-65.8) 0.09
WOMAC function 18 27.7 (15.4-40.0) 14 39.2 (25.0-53.4) 15 52.7 (38.9-66.6) 0.03
AQoL 18 0.60 (0.47-0.73) 14 0.56 (0.41-0.71) 15 0.32 (0.18-0.47) 0.02
MAPT 16 2.2 (0.0-17.4) 14 3.8 (1.9-27.8) 15 39.7 (9.6-58.6) 0.01
Knee arthritis
WOMAC pain 34 24.2 (16.1-32.3) 48 25.9 (19.1-32.6) 65 34.0 (28.2-39.8) 0.09
WOMAC stiffness 34 25.6 (17.2-34.0) 49 30.1 (23.1-37.0) 66 40.6 (34.6-46.7) 0.01
WOMAC function 33 20.7 (12.7-28.7) 48 26.6 (20.0-33.2) 65 35.9 (30.2-41.6) 0.01
AQoL 35 0.68 (0.59-0.77) 49 0.64 (0.57-0.72) 65 0.59 (0.52-0.65) 0.24
MAPT 34 0.0 (0.0-5.3) 44 0.0 (0.0-9.4) 58 6.1 (0.0-23.7) 0.01
Knee osteoarthritis
WOMAC pain 15 23.4 (10.9-35.8) 26 24.0 (14.6-33.4) 47 40.1 (33.0-47.1) 0.01
WOMAC stiffness 15 24.0 (11.3-36.6) 27 29.2 (19.8-38.5) 48 44.3 (37.3-51.4) 0.01
WOMAC function 14 20.1 (7.6-32.6) 27 24.0 (15.1-33.0) 47 40.6 (33.7-47.4) <0.01
AQoL 15 0.65 (0.52-0.79) 27 0.63 (0.53-0.73) 46 0.53 (0.46-0.61) 0.20
MAPT 15 2.5 (0.0-6.6) 26 2.5 (0.0-7.2) 43 12.9 (0.0-39.9) 0.01
WOMAC and AQoL data presented as adjusted mean (95%CI); p-values from ANCOVA with adjustment for age and sex.
MAPT data presented as median (interquartile range); p-values from Kruskal-Wallis test.
Higher WOMAC score indicates higher pain, greater stiffness or worse function; higher MAPT score indicates greater disease severity; lower AQoL score indicates
lower HRQoL.
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http://www.biomedcentral.com/1471-2474/13/254the highest odds of hip arthritis, knee arthritis and knee
OA. Regardless of diagnosis, obesity was consistently
associated with reduced physical function and greater
disease severity, and people with hip arthritis or hip OA
who were obese also experienced very low HRQoL,
compared with population norms. Generating data on
both odds of joint disease and the personal impact of con-
current obesity and joint disease (in terms of pain, func-
tion, HRQoL and disease severity), this study provides new
information which is relevant for clinicians, health planners
and policy makers. Our use of a population-based sampling
frame is a key strength which should improve generalisabil-
ity of the findings across the disease severity spectrum, in
comparison to clinically-based studies which typically in-
volve people with more severe joint disease who are
already receiving care. As in many developed countries,
obesity poses a significant public health problem for Aus-
tralia, with recent data indicating that 68% and 55% of men
and women, respectively, are overweight or obese [46].Arthritis (including OA) and obesity have both been desig-
nated as National Health Priority Areas in Australia [47],
reflecting their current and anticipated burden to the com-
munity. Reducing the burden of concurrent obesity and
joint disease will undoubtedly require a multi-faceted ap-
proach which incorporates primary and secondary preven-
tion programs, improved public education about weight
loss, physical activity and joint protection, and appropriate
support for clinicians to provide effective education and
evidence-based care.
While comparisons across prevalence studies are difficult
due to variation in case definitions (e.g. ‘symptomatic’, ‘radio-
graphic’ and ‘doctor-diagnosed’ arthritis or OA), our find-
ings are in line with studies from the US, the Netherlands,
England and Norway which have consistently demon-
strated that obesity is associated with an increased risk of
knee OA [7,10,12,48,49]. The association between obesity
and prevalence of hip OA is less clear [6]; some studies
have identified a greater risk with increased BMI (AOR
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(AOR 1.0, 95%CI 0.7-1.5 [10] and 1.11, 95%CI 0.41-2.97
[11]). We did not find a significant association between
obesity and odds of hip OA (AOR 1.62, 95%CI 0.77-3.45),
but these analyses were based on a relatively small sam-
ple with limited power. We observed that obesity was
associated with increased odds of hip arthritis, although
this was considerably lower than for knee arthritis or
knee OA (AOR 2.18 vs 5.47 and 7.35, respectively). It
has been suggested that excessive weight may exert a
greater impact on the knee joint through biomechanical
factors, to which the more stable hip joint might be less
susceptible [50].
Although the specific pattern of impairment varied some-
what according to diagnosis, this study provides new
evidence of the association between obesity and burden of
arthritis and OA. Among those with arthritis or OA, obese
individuals reported more pain (for hip arthritis, hip OA
and knee OA), greater stiffness (for hip arthritis, knee arth-
ritis and knee OA), worse function (for all diagnoses), lower
HRQoL (for hip arthritis and hip OA) and greater disease
severity (for all diagnoses). To date, population-based
research into the personal impact of obesity and hip or
knee OA has been limited. Most studies have involved
patients in clinical settings [17,21-24,51], including those
with end-stage OA awaiting hip replacement [52]. However,
the observed relationships between poorer function and
obesity are consistent with previous studies that have
reported reduced physical function [22,52,53], lower phys-
ical activity [17] and greater disability [24,27,28] with
increasing BMI. Further research is needed to investigate
specific mechanisms for reduced function and identify
potential avenues for rehabilitation. An important finding
was that although HRQoL was lower than Australian
norms across each diagnosis group [39], obese individuals
with hip arthritis or hip OA clearly had very poor HRQoL.
This highlights the substantial personal impact of concur-
rent obesity and hip joint disease. Lower quality of life was
also evident in a large study of primary care patients with
hip or knee OA who were overweight or obese [17], but
separate hip and knee analyses were not reported. We did
not find an association between obesity and HRQoL in
knee arthritis or knee OA, similar to a population-based
study of Japanese women [54]. Some clinical studies have
looked at associations between obesity and indicators of dis-
ease severity (e.g. WOMAC) [22,23], and our use of the
MAPT instrument provides further insight into this relation-
ship. In view of rising obesity rates, the observed relation-
ship between obesity and disease severity may have
potential implications for health services demand. However,
our analyses indicate substantial within-group variability
and further investigation should involve larger samples.
While an individual’s understanding of their arthritis type
may be limited, our methods were similar to otherpopulation-based studies (including the Australian National
Health Survey) which have asked participants specifically
about ‘osteoarthritis’ [11,55]. As OA is the most common
form of arthritis [56], our use of the terms ‘arthritis’ and
‘osteoarthritis’ in the screening questions should have cap-
tured the majority of hip and knee OA cases. However, we
acknowledge that self-reported data can be inaccurate. Our
analyses may also underestimate the prevalence of doctor-
diagnosed arthritis and OA, given the additional partici-
pants who reported positive x-rays but did not report
having been told they had arthritis or OA. We excluded this
group from our analyses, in line with previous recommen-
dations [57].
A major strength of our study was the use of federal
electoral rolls to sample the Australian adult population;
however, the main limitation is the low response rate
(23%). Australian government-funded population health
surveys commonly use Computer Assisted Telephone
Interviews or face-to-face interviews and have reported
participation rates of approximately 65% [13,14]. It is
possible that people are more likely to participate in
government-branded research [58] and there may be a
greater community awareness of these ongoing surveys.
Comparing response rates between population-based
studies of joint disease is difficult, due to differences in
recruitment scope (e.g. local, regional or national sam-
pling), differences in the way potential participants are
approached (e.g. with a preliminary telephone call or
introductory letter) and possible cultural differences be-
tween settings which could affect research participation.
We found that younger individuals were less likely to
participate, similar to a population-based study of knee,
hip and hand OA in Norway which also found that
younger individuals were less likely to respond to mailed
questionnaires [49]. Although differential response rates
according to age could potentially introduce bias, we do
not expect this to have impacted significantly on our
results given that our data show the prevalence of joint
disease to be low among younger people. Additionally,
we included age as a predictor in our regression models
and as a covariate in the ANCOVA analyses. Despite the
response rate, the sample can be considered broadly rep-
resentative of the Australian population across several
key characteristics. BMI distribution was similar to that
reported by the Australian Bureau of Statistics (39% under-
weight/normal weight, 37% overweight and 24% obese
[46]. Sixty-seven per cent of the sample lived in a metro-
politan area, compared with 58% from overall Australian
electoral roll data [59]. Although the study sample com-
prised a greater proportion of people from higher SES
areas (21% and 17% living in the ninth and tenth SEIFA
deciles, respectively), higher education status closely
reflected Australian government data on educational at-
tainment [60]. In a 2011 report, 62% of Australians aged
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education or university), which is comparable to that
reported by our sample (61% when limited to those aged
less than 65 years). Additionally, average HRQoL for the
overall sample was similar to Australian population norms
(mean (SD) AQoL score for sample 0.81 (0.21) versus
population norm 0.83 (0.20) [39]).
We also acknowledge that self-reported height and
weight information may underestimate true BMI [15,61]
and that our cross-sectional design precludes causal infer-
ences. It is therefore unknown, for example, whether obes-
ity led to reduced physical function or if lower function
due to OA resulted in weight gain. Finally, although we
included some covariates (age and gender) in the HRQoL
analyses, it is possible that the relationship between BMI
and HRQoL may be affected by other factors, such as
mood or depression, although we did not collect this in-
formation. This study has a number of strengths including
the use of population-based sampling to include people
with a range of joint disease severity, recruitment across
all 8 Australian states and territories to maximise general-
isability, and the evaluation of both prevalence and per-
sonal impact (across a range of constructs relevant to
people with joint disease including pain, function, HRQoL
and disease severity). It has generated the first national
data on the obesity-related burden of hip and knee joint
disease in Australia, and provides new evidence from out-
side the US on the relationships between obesity and key
indicators of wellbeing relevant to people with hip and
knee joint disease.
Conclusions
This national study has shown that obesity was associated
with an increased burden of hip and knee joint disease, as
evidenced by higher prevalence and greater impairment in
key indicators of wellbeing. In particular, people with hip
arthritis or hip OA who were obese had extremely low
HRQoL. While relationships between obesity, pain, function
and HRQoL are likely to be complex, these data highlight
the need for public health interventions that consider over-
weight and obesity as both primary and secondary interven-
tion targets for people with hip or knee joint disease.
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